1061.HK

Essex Bio-Technology Limited [1061.HK] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

1061.HK Stock Summary

Top 10 Correlated ETFs

1061.HK

Top 10 Correlated Stocks

1061.HK

In the News

1061.HK Financial details

Company Rating
-
Market Cap
1.25B
Income
500.67M
Revenue
3.02B
Book val./share
-
Cash/share
-
Dividend
0.07
Dividend %
2.94%
Employees
1.48K
Optionable
No
Shortable
Yes
Earnings
18 Mar 2024
P/E
6.06
Forward P/E
-
PEG
0.48
P/S
1.03
P/B
0.79
P/C
-
P/FCF
13.53
Quick Ratio
0.97
Current Ratio
2.16
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.88
EPS next Y
-
EPS next Q
-
EPS this Y
23.08%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-1.59%
Revenue last 5Y
5.93%
Revenue Q/Q
-10.25%
EPS Q/Q
-36.67%
-
-
-
-
SMA20
30.72%
SMA50
63.77%
SMA100
54.45%
Inst Own
-
Inst Trans
-
ROA
8%
ROE
13%
ROC
0.13%
Gross Margin
90%
Oper. Margin
21%
Profit Margin
17%
Payout
24%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.96-3.94
52W High
+49.33%
52W Low
+348%
RSI
61.21
Rel Volume
7.5
Avg Volume
125.32K
Volume
940K
Perf Week
9.54%
Perf Month
59.43%
Perf Quarter
66.54%
Perf Half Y
61.73%
-
-
-
-
Beta
0.26
-
-
Volatility
0.15%, 0.64%
Prev Close
-1.32%
Price
4.48
Change
2.52%

1061.HK Financial Performance

1061.HK Dividend History

1061.HK Frequently Asked Questions

What is Essex Bio-Technology Limited stock symbol ?

Essex Bio-Technology Limited is a CN stock and trading under the symbol 1061.HK

What is Essex Bio-Technology Limited stock quote today ?

Essex Bio-Technology Limited stock price is $4.48 today.

Is Essex Bio-Technology Limited stock public?

Yes, Essex Bio-Technology Limited is a publicly traded company.

Something similar

Top by Market Cap
AMZ.DE
NVDA
M&M.NS
BRK-A
MIX.JO
Top Correlated ETFs
CBUG.AS
TREI.L
TRE3.L
EL4L.DE
US1.SW
Top Correlated Stocks
3990.HK
0567.HK
LST.L
1930.HK
0149.HK
Similar Market Cap
CLBK
PSRE.L
FMFAX
1198.HK
DLS

Company Profile

Healthcare Drug Manufacturers - Specialty & Generic
  • Volume Average 125.32K
  • Market Capitalization 1.25B
  • Employee 1.48K
  • CEO Dr. Mia Je Ngiam B.Sc.
  • Headquarters Zhuhai,CN
  • IPO Date 2001-06-27
  • Website https://www.essexbio.com

Essex Bio-Technology Limited, an investment holding company, develops, manufactures, distributes, and sells biopharmaceutical products in the People's Republic of China and internationally. The company operates through Ophthalmic Products and Surgical Products segments. It researches and develops basic fibroblast growth factor products for the treatment of cellular proliferation, differentiation, and migration. The company offers Beifushu series, such as Beifushu eye drops, Beifushu eye gel, and Beifushu unit-dose eye drops; Tobramycin eye drops, Levofloxacin eye drops, and Sodium Hyaluronate eye drops, as well as Iodized Lecithin Capsules. It also provides Beifuji sprays and lyophilized powder, and Beifuxin gels for use in burn and scald wounds, acute wounds, surgical incisions, chronic wounds, skin grafting, and other applications. In addition, it offers ophthalmic and surgical products from third parties. Further, the company offers Carisolv dental caries removal gel; and Yi Xue An Granules. It has license agreements with Mitotech S.A. and Mitotech LLC. The company was founded in 1990 and is headquartered in Zhuhai, China.